BioNTech Increases Revenue By More Than 12,500% Thanks To The Coronavirus

Yesterday, the German company BioNTech (BNTX) presented its quarterly results.

Analysts expected its revenue to grow from $41.76 million in August 2020 to $3,250 million, a growth of 7,600% in a single year.

However, expectations fell far short of reality. The company's turnover amounted to $5,310 million, almost double the forecast, a growth in its revenue of close to 12,615%.

This spectacular growth in revenue has not been mirrored in its share price, or at least it had not been until a month ago.

In mid-August 2020, BioNTech shares were trading close to $80 per share, a price similar to that of early 2021. As of mid-July 2021, the stock was slightly above $200 and in the last month, it has taken off.

Some analysts were already announcing that the company's results could be very good due to the new contracts signed by the company to distribute its vaccine in developed countries after the difficulties of AstraZeneca.

The company's prospects are quite good, thanks to its position to combat the coronavirus in developed countries. The need for an extra vaccine dose for reinforcement represents the potential future business, an increasingly close scenario due to the worrying evolution of the delta variant.

Currently, BioNTech's share price stands at $447, an increase of more than 450% in one year compared to an increase of more than 12,500% in the company's revenue.

(Click on image to enlarge)

BioNTech Daily Chart

Source: Admirals MetaTrader 5 - BNTX Daily Chart. Date Range: 9 March 2020 - 10 August 2021. Date Captured: 10 August 2021. Past performance is not a reliable indicator of future results.

The chart above shows the evolution of BioNTech's share price since the 9 March 2020 on a daily basis.

In it you can clearly see the phenomenal bullish rally that the company has enjoyed over the last month.

The upward tip of the exponential moving averages at 20 (blue), 50 (green) and 200 periods (red) indicates that it is buyers who currently hold the market power and that the uptrend continues.

1 2
View single page >> |

Disclaimer: The given data provides additional information regarding all analysis, estimates, prognosis, forecasts or other similar assessments or information (hereinafter ...

How did you like this article? Let us know so we can better customize your reading experience.


Leave a comment to automatically be entered into our contest to win a free Echo Show.